Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

about

Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin

P2860

Q58576944-6920880D-980D-4612-BD99-41234CA91D48

P2860

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

Item

http://www.wikidata.org/entity/Q53758887

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

@en

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

@nl

type

Item

label

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

@en

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

@nl

prefLabel

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

@en

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

@nl

P1476

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls

@en

P2093

M J Ornstrup

http://www.w3.org/2001/XMLSchema#string

M K Poulsen

http://www.w3.org/2001/XMLSchema#string

S Nielsen

http://www.w3.org/2001/XMLSchema#string

T N Kjær

http://www.w3.org/2001/XMLSchema#string

P2860

Use and abuse of HOMA modeling

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals.

Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease.

Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.

Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans.

P2888

ijo.2016.223

P304

262-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/IJO.2016.223

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27916988

http://www.w3.org/2001/XMLSchema#string

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

about

P2860

P2860

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698